Jacobson K A, Fischer B, Ji X D
Molecular Recognition Section, National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.
Bioconjug Chem. 1995 May-Jun;6(3):255-63. doi: 10.1021/bc00033a004.
A general approach for reversible affinity labeling of receptors has been developed. The objective is to carry out a series of chemical modifications resulting in a covalently-modified, yet functionally-regenerated, receptor protein that also may contain a reporter group. The ligand recognition site of A1-adenosine receptors in bovine brain membranes was probed to demonstrated the feasibility of this approach. Use of disulfide or ester linkages, intended for cleavage by exposure of the labeled receptor to either reducing reagents or hydroxylamine, respectively, was considered. Binding of the antagonist radioligand [3H]CPX was preserved following incubation of the native receptor with 3 M hydroxylamine, while binding was inhibited by the reducing reagent dithiothreitol (DTT) with an IC50 of 0.29 M. Hydroxylamine displaced specific agonist ([3H]PIA) binding in a noncovalent manner. Specific affinity labels containing reactive isothiocyanate groups were synthesized from XCC (8-4--oxy]phenyl]-1,3-dipropylxanthine) and shown to bind irreversibly to A1-receptors. The ligands were structurally similar to previously reported xanthine inhibitors (e.g., DITC-XAC: (1989) J. Med. Chem. 32, 1043) except that either a disulfide linkage or an ester linkage was incorporated in the chain between the pharmacophore and the isothiocyanate-substituted ring. These groups were intended for chemical cleavage by thiols or hydroxylamine, respectively. Radioligand binding to A1-receptors was inhibited by these reactive xanthines in a manner that was not reversed by repeated washing. Hydroxylamine or DTT restored a significant fraction of the binding of [3H]CPX in A1-receptors inhibited by the appropriate cleavable xanthine isothiocyanate derivative.
已开发出一种用于受体可逆亲和标记的通用方法。目的是进行一系列化学修饰,从而得到一种经共价修饰但功能可恢复的受体蛋白,该蛋白还可能含有一个报告基团。对牛脑膜中A1 - 腺苷受体的配体识别位点进行了探测,以证明该方法的可行性。考虑使用二硫键或酯键,分别通过将标记的受体暴露于还原剂或羟胺来进行裂解。天然受体与3 M羟胺孵育后,拮抗剂放射性配体[3H]CPX的结合得以保留,而还原剂二硫苏糖醇(DTT)以0.29 M的IC50抑制结合。羟胺以非共价方式取代特异性激动剂([3H]PIA)的结合。由XCC(8 - 4 - -氧基]苯基]-1,3 - 二丙基黄嘌呤)合成了含有反应性异硫氰酸酯基团的特异性亲和标记物,并显示其与A1受体不可逆结合。这些配体在结构上与先前报道的黄嘌呤抑制剂(例如,DITC - XAC: (1989) J. Med. Chem. 32, 1043)相似,只是在药效基团和异硫氰酸酯取代环之间的链中引入了二硫键或酯键。这些基团分别旨在通过硫醇或羟胺进行化学裂解。这些反应性黄嘌呤以一种经反复洗涤不能逆转的方式抑制放射性配体与A1受体的结合。羟胺或DTT可恢复在被适当的可裂解黄嘌呤异硫氰酸酯衍生物抑制的A1受体中[3H]CPX结合的很大一部分。